LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Clinical trials for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough blood cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two targeted drugs (dasatinib and venetoclax) plus chemotherapy in children and young adults up to age 21 whose leukemia or lymphoma has come back or not responded to treatment. The goal is to find the safest dose and see how well the drugs shrin…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy offers hope for kids with Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a combination of the targeted drug trametinib with standard chemotherapy drugs (dexamethasone, cyclophosphamide, and cytarabine) in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to treatment. The goal is to find t…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with Hard-to-Treat blood cancers: drug cocktail trial launches
Disease control Recruiting nowThis study tests a combination of two targeted drugs (ruxolitinib and venetoclax) plus chemotherapy in children and young adults up to age 21 whose leukemia or lymphoma has returned or not responded to treatment. The goal is to find the safest dose and see how well the drugs shri…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 11, 2026 20:53 UTC